Ajulemic acid (IP-751): Synthesis, proof of principle, toxicity studies, and clinical trials

Overview of attention for article published in The AAPS Journal, June 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)

Mentioned by

twitter: 1 X user
patent: 8 patents

wikipedia: 2 Wikipedia pages
googleplus: 2 Google+ users

Citations

dimensions_citation: 37 Dimensions

Readers on

mendeley: 73 Mendeley

Summary X Patents Wikipedia Google+ Dimensions citations

So far, Altmetric has seen 8 patents that reference this research output.

ULTRAPURE TETRAHYDROCANNABINOL-11-OIC ACIDS

Application EP-3851101-A1

European Patent Office

COMPOSITIONS OF AJULEMIC ACID AND USES THEREOF

Application WO-2021072325-A1

World Intellectual Property Organisation (WIPO)

TETRAHYDROCANNABINOL-11-OIC ACIDS FOR USE IN METHODS OF TREATING FIBROTIC DISEASES

Application EP-3620211-A1

European Patent Office

METHODS FOR THE TREATMENT OF INFECTION

Application EP-3448377-A4

European Patent Office

ULTRAPURE TETRAHYDROCANNABINOL-11-OIC ACIDS

Application EP-2956133-A4

European Patent Office

METHODS OF TREATING FIBROTIC DISEASES USING TETRAHYDROCANNABINOL-11-OIC ACIDS

Application EP-2717692-A4

European Patent Office

METHODS OF TREATING FIBROTIC DISEASES USING TETRAHYDROCANNABINOL-11-OIC ACIDS

Application EP-2717692-A1

European Patent Office

METHODS OF TREATING FIBROTIC DISEASES USING TETRAHYDROCANNABINOL-11-OIC ACIDS

Application WO-2012170290-A1

World Intellectual Property Organisation (WIPO)